Zenalux Biomedical Unveils the Zenascope PC1
Biological tissue spectrometer quickly and non-destructively measures physiology and morphology… DURHAM, NC – MARCH 21, 2013 – Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is now...
View ArticleZenalux Announces Research Partnership Program for the Development of New...
Zenascope™ effectively and non-destructively monitors key tissue biomarkers in real-time… DURHAM, NC – APRIL 2, 2013 – Zenalux Biomedical, Inc., a biomedical diagnostics company, announces a Research...
View ArticleZenalux Collaborates with Leading Academic Medical Center Through Research...
Zenascope C49 to be used in a breast tumor margin analysis study… DURHAM, NC – MAY 23, 2013 – Zenalux Biomedical, Inc., a biomedical diagnostics company, announces Duke University as a Zenalux...
View ArticleZenalux Research Partnership with Roswell Park Cancer Institute – Deploys...
Zenalux and Roswell collaborating through Research Partnership program… DURHAM, NC – AUGUST 20, 2013 – Zenalux Biomedical, Inc., a biomedical diagnostics company, is now collaborating with Roswell...
View ArticleZenalux Adds Tulane University to Growing List of Research Partners
Zenalux and Tulane collaborate to monitor tumor response to investigational cancer therapy… DURHAM, NC – JANUARY 23, 2014 – Zenalux Biomedical, Inc., a biomedical diagnostics company, has further...
View ArticleZenalux Adds Pressure Sensing Capability to Zenascope™ System for Data...
Pressure reading function allows users to dial in target pressure via user interface… DURHAM, NC – FEBRUARY 17, 2014 – Zenalux Biomedical, Inc., a biomedical diagnostics company, has improved...
View ArticleZenalux Collaborates with Roswell Park Cancer Institute to Enhance Zenascope™...
Enhanced functionality includes imaging capability, autofluorescence DURHAM, NC – APRIL 22, 2014 – Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer...
View ArticleZenascope Aids in the Screening and Detection of Cervical Cancer in...
Application, findings presented at U.S. Investigators’ Symposium on Global NCD Research ATLANTA, GA – October 8, 2014 – Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, presented its...
View ArticleZenascope Determines Presence or Lack of Blood Flow During Kidney Surgery
Study was the first of its kind conducted using quantitative optical spectroscopy measurement for partial ischemia during partial nephrectomy DURHAM, NC – January 06, 2015 – Zenalux Biomedical, Inc.,...
View ArticleZenalux Announces Grants from the National Institute of Health for Cancer...
Grants pave the way for cervical cancer screening studies in Latin America, Africa, and India DURHAM, NC – November 4, 2015 – Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, has been...
View Article
